Press "Enter" to skip to content

FDA is Expected to Authorize Covid 19 Booster Shots for 12 to 15 Years

The US Food and Drug Administration is expected to broaden eligibility for Pfizer Covid-19 vaccine Booster to youths ages 12 to 15 in the coming days, according to a person familiar with the agency’s plan.People as young as 16 are already eligible to receive Booster of the Pfizer vaccine six months after their two-dose series.

Youths ages 12 to 15 have been eligible to receive the Pfizer Covid-19 vaccine since May; as of early July, about 4 million people in this age group had been fully vaccinated and would be eligible for a Booster immediately.US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said that the FDA is now looking at that.

FDA is Expected to Authorize Covid 19 Booster Shots for 12 to 15 YearsThe CDC will swiftly follow as soon as we hear from them, and I’m hoping to have that in the days to weeks ahead.US health officials have been pushing for months for adults to get boosted, especially after the emergence of the Omicron variant.Studies have shown that the two-dose Pfizer and BioNTech vaccine does not provide sufficient protection against infection with Omicron, although it still appears to help protect against severe disease.

A Booster dose increased protection significantly, studies have shown.The latest timeline for people ages 12 to 15 was first reported by The New York Times. The Times also said that the schedule would shift from six months after the primary dose series to five months, and a Booster shot is expected to be authorized for children ages 5 to 11 with immune deficiencies

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *